Green Cross Labcell rises 9.03% amid umbilical cord blood theme uptrend

On the 11th, the umbilical cord blood theme rose by 4.01% compared to the previous day, showing strength, while Green Cross Labcell, which is attracting attention as a related stock, surged by 9.03% compared to the previous day. Green Cross Labcell is known as a cell therapy research and development company.

[Graph] Major stock price changes in the umbilical cord blood theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Green Cross Labcell ranked 2nd out of 7 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Green Cross Labcell having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial scores are results analyzed by the Robo Algorithm based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.